SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001453687-24-000070
Filing Date
2024-04-19
Accepted
2024-04-19 16:49:33
Documents
5
Period of Report
2024-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1713559759.html 3  
1 FORM 3 wk-form3_1713559759.xml 3 6840
2 EX-24 cartesian-edgarpowerofat.htm EX-24 5259
3 cartesian-edgarpowerofat001.jpg GRAPHIC 247936
4 cartesian-edgarpowerofat002.jpg GRAPHIC 61691
5 cartesian-edgarpowerofat003.jpg GRAPHIC 38959
  Complete submission text file 0001453687-24-000070.txt   493922
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Issuer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CARTESIAN THERAPEUTICS, INC. 704 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address
English Emily (Reporting) CIK: 0002019791 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37798 | Film No.: 24858477